Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV)
Sponsored by Stratejik Yenilikci Girisimler Ltd.
About this trial
Last updated 4 years ago
Study ID
SYG-RMS-18
Status
Completed
Type
Interventional
Phase
Phase 1
Placebo
No
Accepting
18 to 80 Years
All Sexes
Trial Timing
Ended 4 years ago
What is this trial about?
Comparison of treatment efficacy of an automated robotic maneuvering system (RMS) repositioning chair versus manual positioning maneuvers in Benign Paroxysmal Positional Vertigo.
What are the participation requirements?
Inclusion Criteria
* Characteristic positional nystagmus (for BPPV)
* Positive Dix-Hallpike
* Positive supine roll test
* Positive Deep Head Hanging
* Vertigo-Dizziness Imbalance symptom scores compatible with BPPV
Exclusion Criteria
* Pregnant patients
* Patients who have taken vertigo suppressing agents (Dimenhydrinate) in the last 48 hours
* Patients taller than 200 cm (2.0 m)
* Patients who have had a cardiovascular or neurosurgical operation in the last month
* Patients with retinal detachment and/or glaucoma
* Lack of treatment cooperation